Recombinant DNA revisited
Singer, M.
Science 209(4463): 1317
1980
ISSN/ISBN: 0036-8075 PMID: 7414317 Document Number: 161869
Document emailed within 1 workday
Related Documents
Wallerstein, R.S. 1980: Diagnosis revisited (and revisited): the case of hysteria and the hysterical personality International Journal of Psychoanalytic PsychoTherapy 8: 533-548Ravi, V.; King, T.Piao.; Andersen, J.F.; Nutman, T.B.; Neva, F.A. 2005: Strongyloides stercoralis recombinant NIE antigen shares epitope with recombinant Ves v 5 and Pol a 5 allergens of insects American Journal of Tropical Medicine and Hygiene 72(5): 549-553
Talmadge, J.E.; Tribble, H.R.; Pennington, R.W.; Phillips, H.; Wiltrout, R.H. 1987: Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice Cancer Research 47(10): 2563-2570
Holloway, C.J. 1994: Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor European Journal of Cancer 30a Suppl 3: S2-S6
Wu, Z.; Wu, X.; Hou, Y. 2002: Generation of a series of recombinant herpes simplex viruses which can provide replicating and packaging functions for recombinant adeno-associated virus Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 16(1): 74-78
Char, S.; Colston, M.J.; Mitchison, N.A.; Simon, K. 1990: Purification of recombinant Mycobacterium leprae 65-kilodalton antigen and murine antibody responses to intravenously administered recombinant protein Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 41(3): 336-338
McMannis, J.D.; Fisher, R.I.; Creekmore, S.P.; Braun, D.P.; Harris, J.E.; Ellis, T.M. 1988: In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2 Journal of Immunology 140(4): 1335-1340
Fincke, U.; Schneider, J.; Friderichs, E.; Giertz, H.; Flohé, L. 1988: Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model Arzneimittel-Forschung 38(1): 138-142
Jurincic-Winkler, C.; Horlbeck, R.; Klippel, K.F. 1993: Combination therapy with recombinant interferon alpha-21 (rIFN alpha 2a) and recombinant interleukin 2 (rIL-2) in metastatic renal cell cancer Wiener Klinische Wochenschrift 105(10): 271-276
Abbruzzese, J.L.; Levin, B.; Ajani, J.A.; Faintuch, J.S.; Saks, S.; Patt, Y.Z.; Edwards, C.; Ende, K.; Gutterman, J.U. 1989: Phase i trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer Cancer Research 49(14): 4057-4061
Dabrowski, S.; Kur, J. 1998: Recombinant His-tagged DNA polymerase. I. Cloning, purification and partial characterization of Thermus thermophilus recombinant DNA polymerase Acta Biochimica Polonica 45(3): 653-660
Xia, H.Z.; Du, Z.; Craig, S.; Klisch, G.; Noben-Trauth, N.; Kochan, J.P.; Huff, T.H.; Irani, A.M.; Schwartz, L.B. 1997: Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type i expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells Journal of Immunology 159(6): 2911-2921
Drize, N.; Chertkov, J.; Zander, A. 1995: Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) Experimental Hematology 23(11): 1180-1186
Kownatzki, E.; Kapp, A.; Uhrich, S. 1988: Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human lymphotoxin. Promotion of adherence, inhibition of chemotactic migration and superoxide anion release from adherent cells Clinical and Experimental Immunology 74(1): 143-148
Ottmann, O.G.; Abboud, M.; Welte, K.; Souza, L.M.; Pelus, L.M. 1989: Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors Experimental Hematology 17(2): 191-197
Bialas, T.; Kolitz, J.; Levi, E.; Polivka, A.; Oez, S.; Miller, G.; Welte, K. 1988: Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin Cancer Research 48(4): 891-898
Cowan, H.H. 1984: SB-646 revisited Journal of the Kansas Medical Society 85(12): 333-334
Bleifeld, C.J. 1979: Aequanimitas revisited Surgery Gynecology and Obstetrics 148(3): 419
Kolobow, T.; Gattinoni, L.; Pesenti, A.; Solca, M.; Fumagalli, R.; Moretti, M.; Mascheroni, D.; Prato, P.; Borelli, M. 1987: ECMO revisited International Journal of Artificial Organs 10(1): 1-2
Olivier, H.; Fitz-Gerald, M.J.; Babiak, B. 1998: Benzodiazepines revisited Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 150(10): 483-485